These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis. Shimada M; Kawahara H; Ozaki K; Fukura M; Yano H; Tsuchishima M; Tsutsumi M; Takase S Am J Gastroenterol; 2007 Sep; 102(9):1931-8. PubMed ID: 17511754 [TBL] [Abstract][Full Text] [Related]
24. Serum cytokeratin-18 fragment level: a noninvasive biomarker for not only nonalcoholic steatohepatitis, but also alcoholic steatohepatitis. Li X; Zhang Y; Wu K; Fan D Hepatology; 2010 May; 51(5):1865-6. PubMed ID: 20041411 [No Abstract] [Full Text] [Related]
25. Significance and practicability of Normotest in diagnosis of chronic liver diseases. Henning H; Yano M Scand J Gastroenterol Suppl; 1973; 19():119-23. PubMed ID: 4515634 [No Abstract] [Full Text] [Related]
26. Pathology of nonalcoholic fatty liver disease. Yeh MM; Brunt EM Am J Clin Pathol; 2007 Nov; 128(5):837-47. PubMed ID: 17951208 [TBL] [Abstract][Full Text] [Related]
27. Non alcoholic steatohepatitis. Zantout H; Barada K J Med Liban; 2001; 49(2):90-3. PubMed ID: 11910973 [No Abstract] [Full Text] [Related]
33. Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents. Schwimmer JB Semin Liver Dis; 2007 Aug; 27(3):312-8. PubMed ID: 17682977 [TBL] [Abstract][Full Text] [Related]
34. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Wieckowska A; McCullough AJ; Feldstein AE Hepatology; 2007 Aug; 46(2):582-9. PubMed ID: 17661414 [TBL] [Abstract][Full Text] [Related]
35. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity]. Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634 [TBL] [Abstract][Full Text] [Related]
36. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease. Miele L; Forgione A; La Torre G; Vero V; Cefalo C; Racco S; Vellone VG; Vecchio FM; Gasbarrini G; Rapaccini GL; Neuman MG; Grieco A Transl Res; 2009 Oct; 154(4):194-201. PubMed ID: 19766963 [TBL] [Abstract][Full Text] [Related]
37. Non-alcoholic steatohepatitis in children. Roberts EA Clin Liver Dis; 2007 Feb; 11(1):155-72, x. PubMed ID: 17544977 [TBL] [Abstract][Full Text] [Related]
38. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease. Pagadala M; Zein CO; McCullough AJ Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307 [TBL] [Abstract][Full Text] [Related]
39. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175 [TBL] [Abstract][Full Text] [Related]
40. Leptin a new biological marker for evaluating malnutrition in elderly patients. Bouillanne O; Golmard JL; Coussieu C; Noël M; Durand D; Piette F; Nivet-Antoine V Eur J Clin Nutr; 2007 May; 61(5):647-54. PubMed ID: 17151588 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]